Anbio Biotechnology (NNNN) Non-Current Assets (2023 - 2024)
Anbio Biotechnology (NNNN) posted Non-Current Assets of $387,440 for the quarter ended Dec 31, 2024, up 523.5% from $62,137 a year earlier.
Powered by 
Analysis
Anbio Biotechnology (NNNN) Non-Current Assets (2023 - 2024) Analysis & Trends
- In prior years, Anbio Biotechnology's Non-Current Assets was $62,137 in the year ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.99 Bn | 237.02 Bn | 4.88 Bn | 89.81 Bn |
| 2 | Abbott Laboratories | 175.01 Bn | 145.44 Bn | 7.27 Bn | 84.70 Bn |
| 3 | Danaher | 164.93 Bn | 148.74 Bn | 3.61 Bn | 78.99 Bn |
| 4 | Intuitive Surgical | 151.84 Bn | 131.26 Bn | 1.96 Bn | 11.33 Bn |
| 5 | Medtronic | 119.05 Bn | 84.30 Bn | 6.34 Bn | 68.92 Bn |
| 6 | Stryker | 113.89 Bn | 100.00 Bn | 4.50 Bn | 33.51 Bn |
| 7 | Boston Scientific | 65.37 Bn | 60.13 Bn | 3.85 Bn | 37.24 Bn |
| 8 | Becton Dickinson | 53.36 Bn | 50.51 Bn | 2.32 Bn | 42.59 Bn |
| 9 | Edwards Lifesciences | 50.83 Bn | 34.83 Bn | 1.35 Bn | 7.05 Bn |
| 10 | Anbio Biotechnology | 162.72 Mn | 115.94 Mn | - | - |
API Access
Anbio Biotechnology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NNNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NNNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NNNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();